André Machado de Siqueira

Oswaldo Cruz Foundation (FIOCRUZ) - Evandro Chagas National Institute of Infectious Diseases (INI)

Av. Brasil 4365

Rio de Janeiro, 21040-360

Brazil

SCHOLARLY PAPERS

1

DOWNLOADS
Rank 2,555

SSRN RANKINGS

Top 2,555

in Total Papers Downloads

19,127

SSRN CITATIONS

0

CROSSREF CITATIONS

5

Scholarly Papers (1)

1.

Efficacy and Safety of a COVID-19 Inactivated Vaccine in Healthcare Professionals in Brazil: The PROFISCOV Study

Number of pages: 66 Posted: 14 Apr 2021
Instituto Butantan, Instituto Butantan, affiliation not provided to SSRN, Instituto Butantan, Instituto Butantan, Instituto Butantan, Instituto Butantan, Institute of Infectious Diseases Emilio Ribas, Federal University of Parana (UFPR), Pontificia Universidade Catolica do Rio Grande do Sul (PUCRS) - School of Medicine, Universidade de Brasília (UnB), Universidade Municipal de São Caetano do Sul (USCS), Hospital Israelita Albert Einstein, Universidade Estadual de Campinas (UNICAMP), University of São Paulo (USP) - Faculdade de Medicina de Ribeirão Preto, Federal University of Pelotas (UFPel), Universidade Federal de Mato Grosso, affiliation not provided to SSRN, Universidade Federal de Mato Grosso do Sul, Oswaldo Cruz Foundation (FIOCRUZ) - Evandro Chagas National Institute of Infectious Diseases (INI), University of São Paulo (USP), Instituto Butantan, Sinovac Biotech CO., Ltd., Sinovac Life Sciences Co., Ltd., Federal University of Minas Gerais (UFMG), Faculdade de Medicina de São José de Rio Preto (FAMERP) and University of São Paulo (USP) - Hospital das Clinicas HCFMUSP
Downloads 19,127 (213)
Citation 55

Abstract:

Loading...

Brazil, COVID-19, COVID-19 Vaccine, Inactivated Vaccines, Phase III Clinical Trial, Randomised controlled trial, protocol